Characteristics of the mean platelet volume, neutrophil to lymphocyte ratio, and C-reactive protein compared to the procalcitonin level in pneumonia patients

Platelets

Volumn 26, Issue 3, 2015, Pages 278-280

  Lee, Jong Han ^a   Yoon, Soo Young ^a   Kim, Hyon Suk ^b   Lim, Chae Seung ^a  

^a Korea University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

C reactive protein; Mean platelet volume; Mean platelet volume platelet count; Neutrophil to lymphocyte ratio; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPHIL LYMPHOCYTE RATIO; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; BLOOD; LYMPHOCYTE; NEUTROPHIL;

BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTES; MEAN PLATELET VOLUME; NEUTROPHILS; PNEUMONIA; PROTEIN PRECURSORS;

EID: 84925940780     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2013.875138     Document Type: Letter

References (22)

1. Michail M, Jude E, Liaskos C, Karamagiolis S, Makrilakis K, Dimitroulis D, Michail O, Tentolouris N. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds 2013;12:94-99.
2. Schuetz P, Christ-Crain M, Muller B. Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr Opin Crit Care 2007;13:578-585.
3. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-Hope for hype? Swiss Med Wkly 2009;139:318-326.
4. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518.
5. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004;39:206-217.
6. Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: A prospective study. Crit Care 2007;11:R38.
7. Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: Review of the literature. Infection 2008;36:396-407.
8. Zeng L, He X, Liu J, Wang L, Weng S, Wang Y, Chen S, Yang GY. Differences of circulating inflammatory markers between large-and small vessel disease in patients with acute ischemic stroke. Int J Med Sci 2013;10:1399-1405.
9. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006;34:1996-2003.
10. Ekiz F, Yuksel O, Kocak E, Yilmaz B, Altinbas A, Coban S, Yuksel I, Uskudar O, Koklu S. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011;25: 162-165.
11. Canpolat F, Akpinar H, Eskioglu F. Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol 2010;29:325-328.
12. Kayahan H, Akarsu M, Ozcan MA, Demir S, Ates H, Unsal B, Akpinar H. Reticulated platelet levels in patients with ulcerative colitis. Int J Colorectal Dis 2007;22:1429-1435.
13. Milovanovic M, Nilsson E, Jaremo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 2004;343:237-240.
14. Yazici S, Yazici M, Erer B, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 2010;21:122-125.
15. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012;5:2.
16. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;137:425-428.
17. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181-184.
18. bioMérieux PCT booklet. Available from http://www.biomerieuxdiagnostics. com/upload/PCT-BOOKLET-GB.pdf [last accessed 18 Dec 2013].
19. Cho SY, Yang JJ, Nam YS, Suh JT, Park TS, Lee HJ. Mean platelet volume in patients with increased procalcitonin level. Platelets 2013; 24:246-247.
20. Azab B, Torbey E, Singh J, Akerman M, Khoueiry G, McGinn JT, Widmann WD, Lafferty J. Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets 2011;22:557-566.
21. Cho SY, Yang JJ, You E, Kim BH, Shim J, Lee HJ, Lee WI, Suh JT, Park TS. Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets 2013;24:375-377.
22. Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer 2013; in press.